Atlas Trials

Gene Therapy for Children With CLN3 Batten Disease

Clinical trial NCT03770572 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03770572
Sponsor
Neela Therapeutics
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CLN3Batten Disease
Start date
2018-11-13
Primary completion
2029-09-30
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.